Pharmacists are a trusted resource for patients navigating the financial struggles, societal stigma, and overall darkness associated with depression. Our review of the pathophysiology, diagnosis criteria, and assessments related to depression and our thorough discussion on guideline-based treatment approaches will assist you as you embrace your role of caring for patients with major depressive disorder.

Upon successful completion of this application-based CPE course, pharmacists should be able to:
1. List the signs, symptoms, and diagnostic criteria of major depressive disorder (MDD)
2. Apply guideline-based treatment algorithms to persons with MDD
3. Develop monitoring plans for persons with MDD and medications used to treat MDD
4. Formulate evidence-based recommendations for persons with MDD
5. Discuss the role of the pharmacy team in the patient journey for persons with MDD 

Amy Werremeyer, PharmD, BCPP
Professor and Chair
Department of Pharmacy Practice
North Dakota State University

Amy Werremeyer has no relevant financial relationships with ineligible companies to disclose. 

Course fee includes course, course materials, and CPE credit submission to CPE Monitor.
Course is non-refundable.
Initial Release Date: September 12, 2023
Planned Expiration Date: September 12, 2026

Copyright 2023, CEimpact. All Rights Reserved. Any reproduction of this course without express permission is strictly forbidden.  

RV1-6.24